Search hospitals > Texas > Houston

The University of Texas Health Science Center at Houston

Claim this profile
Houston, Texas 77030
Global Leader in Stroke
Global Leader in Unintentional Home Injuries
Conducts research for Coronavirus
Conducts research for Systemic Sclerosis
Conducts research for Hypertension
942 reported clinical trials
138 medical researchers
Photo of The University of Texas Health Science Center at Houston in HoustonPhoto of The University of Texas Health Science Center at Houston in HoustonPhoto of The University of Texas Health Science Center at Houston in Houston

Summary

The University of Texas Health Science Center at Houston is a medical facility located in Houston, Texas. This center is recognized for care of Stroke, Unintentional Home Injuries, Coronavirus, Systemic Sclerosis, Hypertension and other specialties. The University of Texas Health Science Center at Houston is involved with conducting 942 clinical trials across 1,172 conditions. There are 138 research doctors associated with this hospital, such as Sean Savitz, Modupe Idowu, MD, Hope Northrup, and Jay-Jiguang Zhu, MD.

Area of expertise

1Stroke
Global Leader
The University of Texas Health Science Center at Houston has run 55 trials for Stroke. Some of their research focus areas include:
anticoagulant
48 hours
2Unintentional Home Injuries
Global Leader
The University of Texas Health Science Center at Houston has run 44 trials for Unintentional Home Injuries.

Top PIs

Clinical Trials running at The University of Texas Health Science Center at Houston

Prostate Cancer
Ovarian Cancer
Stroke
Epilepsy
Frontotemporal Dementia
Diabetes
Invasive Candidiasis
Pulmonary Embolism
Breast Cancer
Atopic Dermatitis
Image of trial facility.

Long-Term Safety of AAA617

for Prostate Cancer

The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \[177Lu\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as possible) any other AAA617 causally related serious adverse event(s) in the long-term in adults with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials.
Recruiting3 awards Phase 4
Image of trial facility.

MGC026

for Cancer

The study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or refractory, unresectable, locally advanced or metastatic solid tumors The study has a dose escalation portion and a cohort expansion portion of the study. Participants will receive MGC026 by intravenous (IV) infusion. The dose of MGC026 will be assigned at the time of enrollment. Participants may receive up to 35 treatments if there are no severe side effects and as long as the cancer does not get worse. Participants will be monitored for side effects, and progression of cancer, have blood samples collected for routing laboratory work, and blood samples collected for research purposes.
Recruiting1 award Phase 1
Image of trial facility.

Digital Health Coaching

for Cancer Survivorship

This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary therapy for cancer. Up to 625 individuals with diverse cancer diagnoses will be enrolled across up to 8 clinical sites to participate in a randomized wait-list control study. Those in the intervention group will receive 6 months of digital coaching up front followed by 6 months of ongoing monitoring via patient reported and clinical outcomes, as well as wearable data. Those in the control group will be monitored via patient reported and clinical outcomes as well as wearable data for the first 6 months followed by 6 months of digital health coaching. Both groups will collect fecal microbiome samples at enrollment and month 6. The study aims to explore if and how digital health coaching may be used to enhance outcomes for individuals following completion of primary cancer therapy.
Recruiting1 award N/A2 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at The University of Texas Health Science Center at Houston?
Where is The University of Texas Health Science Center at Houston located?
Who should I call to ask about financial aid or insurance network?
What insurance does The University of Texas Health Science Center at Houston accept?
What awards or recognition has The University of Texas Health Science Center at Houston received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security